SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wade Spencer Graves who wrote (20841)4/20/1999 11:50:00 AM
From: Brent  Read Replies (1) of 23519
 
Wade,

I agree with you wholeheartedly. This stock needs more support from traders.

VLAD,

I am long Vivus so don't get upset at me, but Vivus has disappointed everyone but the shorts. It will take proof positive and then some before the stock will come back. I know many here think that this 'blowout' was proof Vivus is back and strong, but with a quick glance you can tell Vivus is still only breaking even at best. $4 million milestone divided by the 31.8 million shares gives you $0.125 per share in earnings, so continuing operations are breakeven.

Don't get me wrong, I think it is positive. When international sales pick up and IF we ever get a domestic partner, Vivus should be very profitable. But from a cursory look, these blowout earnings aren't really blowout and the street is taking VVUS back.

The shorts aren't the enemy.

Brent
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext